Multicenter Studies as Topic

"Multicenter Studies as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.

Descriptor ID	D015337
MeSH Number(s)	E05.318.760.658 N05.715.360.775.508 N06.850.520.450.643
Concept/Terms	Multicenter Studies as Topic Multicenter Studies as Topic Multicentre Studies as Topic Multicenter Trials Multicenter Trials Multicenter Trial Trial, Multicenter Trials, Multicenter Multicentre Trials Multicentre Trial Trial, Multicentre Trials, Multicentre

Below are MeSH descriptors whose meaning is more general than "Multicenter Studies as Topic".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Epidemiologic Study Characteristics [E05.318.760]
Multicenter Studies as Topic [E05.318.760.658]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Epidemiologic Study Characteristics [N05.715.360.775]
Multicenter Studies as Topic [N05.715.360.775.508]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Epidemiologic Study Characteristics [N06.850.520.450]
Multicenter Studies as Topic [N06.850.520.450.643]

Below are MeSH descriptors whose meaning is related to "Multicenter Studies as Topic".

Below are MeSH descriptors whose meaning is more specific than "Multicenter Studies as Topic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Multicenter Studies as Topic" by people in this website by year, and whether "Multicenter Studies as Topic" was a major or minor topic of these publications.

Bar chart showing 52 publications over 23 distinct years, with a maximum of 6 publications in 2025

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1999	0	1	1
2002	1	0	1
2003	4	1	5
2004	0	3	3
2005	0	1	1
2006	0	4	4
2007	0	1	1
2008	0	5	5
2010	0	1	1
2012	1	0	1
2013	0	1	1
2015	0	1	1
2016	0	2	2
2017	0	2	2
2018	1	1	2
2019	0	1	1
2020	0	3	3
2021	0	1	1
2022	0	2	2
2023	0	4	4
2024	0	3	3
2025	0	6	6

Below are the most recent publications written about "Multicenter Studies as Topic" by people in Profiles.

Goldenberg I, Zareba W, Ezekowitz JA, Albert C, Alexis JD, Anderson L, Behr ER, Daubert J, Di Palo KE, Ellenbogen KA, Dzikowicz DJ, Harrington JM, Hsich E, Huang DT, Januzzi JL, Jawaid A, Kutyifa V, Lala-Trindade A, Nakonechnyi A, Onwuanyi A, Pi?a IL, Sandhu RK, Sears S, Sroubek J, Baykaner T, Strawderman R, Beck C, Butler J. Rationale and design of the comparative effectiveness of ICD vs non-ICD therapy in contemporary heart failure patients at a low risk for arrhythmic death (CONTEMP-ICD) trial. Am Heart J. 2026 Jan; 291:162-174.

View in: PubMed
McNamara PJ, Chock VY, Rahde-Bischoff A, Gabrio J, Johnson KJ, Harmon HM, Montoya-Williams D, Colaizy TT, Katheria AC, Ines F, Sorrells K, Battersby C, Levy PT, Rysavy MA, Bhombal S, Laughon MM, Carper B, Hintz SR, Das A, Bell EF. Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trial. BMJ Open. 2025 Aug 26; 15(8):e105018.

View in: PubMed
Dang L, Kroenke K, Connors J, Stump TE, Monahan PO, Chernyak Y, Holmes E, Hoffman C, Prather K, Musey PI. Psychological Comorbidity in Patients Presenting to the Emergency Department With Low-Risk Chest Pain and Anxiety. Acad Emerg Med. 2026 Jan; 33(1):e70113.

View in: PubMed
Conrad AL, DeMauro SB, Kirpalani H, Ziolkowski K, Hintz SR, Vohr BR, Watson V, Colaizy TT, Bell EF, Brumbaugh JE, Bann CM, Tan SM, Newman JE, Das A. The transfusion of prematures early school age follow-up (TOP 5): protocol for a longitudinal cohort study. BMC Pediatr. 2025 May 15; 25(1):387.

View in: PubMed
Ramos-Benitez MJ, Miao R, Rivera-Torres AP, Lacourt-Ventura M, Malavez-Cajigas SJ, Tian X, Teague HL, De Jesus-Rojas W, Reger R, Suffredini AF, King C, Nathan SD, Childs RW, Strich JR. Surfactant Protein D and Club Cell Secretory Protein as Biomarkers of Disease Severity and Fostamatinib Efficacy in Severe COVID-19. Crit Care Explor. 2025 Apr 01; 7(4):e1252.

View in: PubMed
Yue M, Gaietto K, Han YY, Rosser FJ, Xu Z, Qoyawayma C, Acosta-Perez E, Canino G, Forno E, Chen W, Celed?n JC. Transcriptomic Profiles in Nasal Epithelium and Asthma Endotypes in Youth. JAMA. 2025 01 28; 333(4):307-318.

View in: PubMed
Vergote I, Perez Fidalgo A, Valabrega G, Monk BJ, Herzog T, Cibula D, Colombo N, Pothuri B, Sehouli J, Korach J, Barlin J, Papadimitriou CA, van Gorp T, Richardson D, McCarthy M, Antill Y, Mirza MR, Li K, Kalyanapu P, Slomovitz B, Coleman RL. ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. Int J Gynecol Cancer. 2024 08 05; 34(8):1283-1289.

View in: PubMed
Skaar TC, Myers RA, Fillingim RB, Callaghan JT, Cicali E, Eadon MT, Elwood EN, Ginsburg GS, Lynch S, Nguyen KA, Obeng AO, Park H, Pratt VM, Rosenman M, Sadeghpour A, Shuman S, Singh R, Tillman EM, Volpi S, Wiisanen K, Winterstein AG, Horowitz CR, Voora D, Orlando L, Chakraborty H, Van Driest S, Peterson JF, Cavallari LA, Johnson JA, Dexter PR. Implementing a pragmatic clinical trial to tailor opioids for chronic pain on behalf of the IGNITE ADOPT PGx investigators. Clin Transl Sci. 2024 Aug; 17(8):e70005.

View in: PubMed
Hines LJ, Wilke RA, Myers R, Mathews CA, Liu M, Baye JF, Petry N, Cicali EJ, Duong BQ, Elwood E, Hulvershorn L, Nguyen K, Ramos M, Sadeghpour A, Wu RR, Williamson L, Wiisanen K, Voora D, Singh R, Blake KV, Murrough JW, Volpi S, Ginsburg GS, Horowitz CR, Orlando L, Chakraborty H, Dexter P, Johnson JA, Skaar TC, Cavallari LH, Van Driest SL, Peterson JF. Rationale and design for a pragmatic randomized trial to assess gene-based prescribing for SSRIs in the treatment of depression. Clin Transl Sci. 2024 06; 17(6):e13822.

View in: PubMed
Igwe JK, Wangdak Yuthok TY, Cruz E, Mueller A, Lan RH, Brown-Johnson C, Idris M, Rodriguez F, Clark K, Palaniappan L, Echols M, Wang P, Onwuanyi A, Pemu P, Lewis EF. Opportunities to Increase Science of Diversity and Inclusion in Clinical Trials: Equity and a Lack of a Control. J Am Heart Assoc. 2023 12 19; 12(24):e030042.

View in: PubMed

People

Explore

Similar Concepts

Top Journals